This disclosure relates to portable devices for detecting various virus antibodies for the detection of virus diseases. Viral infections, such as those from SARS-CoV family viruses, HIV family viruses, and other family viruses can be detected by their antibodies or DNA in a clinical specimen.

A fluidic device includes a first circulation flow path and a second circulation flow path which circulate a solution containing a sample material, the first circulation flow path and the second circulation flow path share at least a part of the flow path, and at least one selected from the group consisting of a capture unit which captures the sample material, a detection unit which detects the sample material, a valve, and a pump is provided on the shared flow path.

A method of performing an optical measurement of an analyte in a processed biological sample using a cartridge is provided. The cartridge is operable for being spun around a rotational axis. The method comprises: placing the biological sample into a sample inlet; controlling the rotational rate of the cartridge to process a biological sample into the processed biological sample using a fluidic structure; controlling the rotational rate of the cartridge to allow the processed biological sample to flow from the measurement structure inlet to an absorbent structure via a chromatographic membrane, and performing an optical measurement of a detection zone on the chromatographic membrane with an optical instrument. An inlet air baffle reduces evaporation of the processed biological sample from the chromatographic membrane during rotation of the cartridge.

Proposed are an all-in-one kit for on-site molecular diagnosis and a molecular diagnosis method using the same. The kit includes a first component including a sample pre-processing part, a nucleic acid adsorption part, and a nucleic acid amplification part, and a second component including a detection part. The sample pre-processing part includes a transfer member for transferring a lysis buffer where a nucleic acid is dissolved and functions to pre-processes a sample. The nucleic acid adsorption part is positioned on the sample pre-processing part and is configured to be slidable onto the nucleic acid amplification part. The nucleic acid amplification part is connected to the sample pre-processing part and functions to elute the nucleic acid from the nucleic acid adsorption part and to amplify the eluted nucleic acid. The detection part functions to transfer the nucleic acid amplified by the nucleic acid amplification part and to detect the nucleic acid.

A microfluidic device for amplifying a nucleic acid includes a cartridge and a control part. The cartridge includes a tank part and a plurality of first chambers. The control part is configured to control execution of a thermal cycle, count a number of repetitions of the thermal cycle for each of the first chambers and store a count value, acquire a fluorescence intensity of each of the first chambers for each thermal cycle, and reset the count value of a defective chamber of which the fluorescence intensity is not within a predetermined range, discharge the solution from the defective chamber, and fill the defective chamber with a new solution from the tank part.

The present invention provides methods and devices for simple, low power, automated processing of biological samples through multiple sample preparation and assay steps. The methods and devices described facilitate the point-of-care implementation of complex diagnostic assays in equipment-free, non-laboratory settings. The invention includes a microfluidic device comprising a reagent-dispensing unit, a sample extraction device and a specimen processing unit.

A detection cartridge, a detection method, and a detection device are provided. The detection cartridge includes a detection tank, a sample tank, N containers, and at least one first temporary tank. The sample tank is in communication with the detection tank. The N containers are in communication with the detection tank, wherein N is a positive integer greater than or equal to 2. The at least one first temporary tank is disposed on at least one of N flow paths between the N containers and the detection tank, wherein a quantity of the first temporary tanks on an nth flow path in the N flow paths is greater than or equal to that on an (n-1)th flow path, and n is a positive integer that is not less than 2 and is not more than N.

The present disclosure provides devices, systems, methods for processing and/or analyzing a biological sample. An analytic device for processing and/or analyzing a biological sample may comprise a moving carriage. The analytic device may be portable. The analytic device may receive instructions for performing an assay from a mobile electronic device external to a housing of the analytic device.

There are provided methods for quantifying an analyte in a sample, diagnosing a condition characterized by an excess or a depletion of an analyte in a biological sample, isolating analyte from a sample, and detecting an analyte in a sample. These method comprise the steps of providing a colloidal suspension of nanoparticles of a plasmonic metal, the nanoparticles having attached on their surface a binding moiety for selective attachment of said analyte and adding the sample to the suspension, thus producing a mixture in which said analyte is attached to the nanoparticles in suspension. Then, the methods further comprise the steps of either allowing sedimentation of the nanoparticles with bound analyte, thereby producing a sediment comprising the nanoparticles with bound analyte and a supernatant, and measuring the Localized Surface Plasmon Resonance (LSPR) spectrum of the supernatant and/or recovering the sediment, or measuring the Localized Surface Plasmon Resonance (LSPR) spectrum of the mixture.

A biosensor for detecting analytes present in fluid includes one or more plates configured on a substrate to form at least one channel such that one or more containment chambers are formed in the channels. The channel are mechanically, separated from each other by spacers, and the containment chambers are fluidically separated from adjacent chamber by a discontinuity such that the fluid flows between adjacent chambers only after an application of a predefined pressure on the plate. The multiple chambers allows the fluid to undergo pre-processing using different set of reagents provided at different chambers, to mitigate effects of interferents and to efficiently distribute load of the reagents on the chambers. Further, some of containment chambers allows detection of analytes in the fluid using detection reagents.